Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria

International Journal of Urology

Volumn 6, Issue 4, 1999, Pages 173-177

  Miyanaga, Naoto ^a   Akaza, Hideyuki ^a,m   Tsukamoto, Taiji ^b   Ishikawa, Satoru ^c   Noguchi, Ryosuke ^d   Ohtani, Mikinobu ^m   Kawabe, Kazuki ^e   Kubota, Yoshinobu ^f   Fujita, Kimio ^g   Obata, Koji ^h   Hirao, Yoshihiko ⁱ   Kotake, Toshihiko ^j   Ohmori, Hiroyuki ^k   Kumazawa, Joichi ^l   Koiso, Kenkichi ^m  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c Hitachi   (Japan)

^d Mito Saiseikai General Hospital   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

ⁱ NARA MEDICAL UNIVERSITY   (Japan)

^j OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^k OKAYAMA UNIVERSITY   (Japan)

^l KYUSHU UNIVERSITY   (Japan)

^m NONE

more..

Author keywords

Hematuria; Nuclear matrix protein 22; Screening; Urine cytology; Urothelial neoplasm

Indexed keywords

MATRIX PROTEIN; MATRIX PROTEIN 22; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER SCREENING; CELL NUCLEUS MATRIX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; FEMALE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MICROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; URINALYSIS; URINARY TRACT CANCER; URINE CYTOLOGY; UROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CYSTITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATURIA; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NUCLEAR PROTEINS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; URINALYSIS; URINARY BLADDER NEOPLASMS; URINARY CALCULI; UROTHELIUM;

EID: 0033499782     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.1999.06437.x     Document Type: Article

References (15)

1. 1 Ritchie CD, Bevan EA, Collier SJ. Importance of occult haematuria found at screening. BMJ 1986; 292: 681-3.
2. 2 Froom P, Ribak J, Benbassat J. Significance of microhaematuria in young adults. BMJ 1984; 288: 20-2.
3. 3 Mohr DN, Offord KP, Owen RA, Melton LJ. Asymptomatic microhaematuria and urologie disease: A population based study. JAMA 1986; 256: 224-9.
4. 4 Britton JP, Dowell AC, Whelan P. Dipstick haematuria and bladder cancer in men over 60: Results of a community study. BMJ 1989; 299: 1010-12.
5. 5 Sutton JM. Evaluation of haematuria in adults. JAMA 1990; 263: 2475-80.
6. 6 Murakami S, Igarashi T, Yamanishi T, Shiseki Y. Clinical study of asymptomatic hematuria. Jpn. J. Urol. 1986; 77: 1078-81.
7. 7 Soloway MS, Briggman y Carpinito GA et al. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol. 1996; 156: 363-7.
8. 8 Miyanaga N, Akaza H, Ishikawa S et al. Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur. Urol. 1997; 31: 163-8.
9. 9 Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 1945; 101: 519-21.
10. 10 Gillatt DA, O'Reilly PH. Haematuria analysed: A prospective study. J. R. Soc. Med. 1987; 80: 559-60.
11. 11 Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J. Urol. 1989; 141: 350-5.
12. 12 Hattori R, Kinukawa T, Matsuura O et al. Clinical importance of microhematuria as an initial sign of urological neoplasma. Jpn. J. Urol. 1988; 79: 1393-8.
13. 13 Britton JP. Effectiveness of haematuria clinics. Br. J. Urol. 1993; 71: 247-52.
14. 14 Webb JAW. Imaging in haematuria. Clin. Radiol. 1997; 52: 167-71.
15. 15 Stonelake PS, Wallase DM. Investigation of adults with haematuria. BMJ 1990; 301: 1396-7.